AMSTERDAM, Jan 27 (Reuters) - The European Medicines Agency (EMA) said on Monday it ... after a group of Democratic state attorneys general last week said that some funds remained frozen.
The ruling requires all trials across the EU to be filed through the European Medicines Agency’s digital filing system.
The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...
Brussels called on Bulgaria to contact the European Medicines Agency (EMA) in the event of ... three months if the Commission or a member state makes a so-called "detailed opinion" expressing ...